Affinité Instruments envisions an immunization monitoring system for billions of people enabling us to reopen the global economy. Our unique approach is to link rapid screening and confirmation testing together and to build an aggregated and anonymized database to be shared with public health agencies and other institutions. In partnership with academia and public health agencies, we are developing a point-of-care platform and a test on dried blood spots that would allow us to streamline screening and testing and deliver a comprehensive annual antibody testing package for less than $50 USD.